<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have used an in situ hybridization method for analysis of expression of BCL2 and MYC on cytospun preparations of <z:mpath ids='MPATH_458'>normal</z:mpath> and malignant lymphoid cell lines and tissue sections of <z:mpath ids='MPATH_458'>normal</z:mpath> and malignant lymph nodes </plain></SENT>
<SENT sid="1" pm="."><plain>The probes comprised 50-mer antisense oligonucleotides starting at the ATG codons of exon 3 of BCL2 and exon 2 of MYC </plain></SENT>
<SENT sid="2" pm="."><plain>We studied the expression of these two genes in frozen tissue sections of biopsy specimens derived from <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:mp ids='MP_0008102'>hyperplastic lymph nodes</z:mp>, B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> carrying the t(14;18)(q32;q21) and t(8;14)(q24;q32) translocations, and T-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> with clonal chromosome abnormalities </plain></SENT>
<SENT sid="3" pm="."><plain>While <z:hpo ids='HP_0000001'>all</z:hpo> proliferating cells expressed both genes, BCL2 expression was increased two- to threefold in follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> with t(14;18) and MYC expression was increased two- to four-fold in high-grade <z:hpo ids='HP_0002665'>lymphomas</z:hpo> with t(8;14) </plain></SENT>
<SENT sid="4" pm="."><plain>These results are consistent with previous data on deregulated expression of these genes obtained from study of <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines carrying the relevant translocations </plain></SENT>
</text></document>